← Back to headlines
EU Approves First Oral GLP-1 Drug for Obesity Treatment
The European Commission has approved Wegovy in tablet form as the first oral GLP-1 receptor agonist for the treatment of obesity and overweight in EU countries, marking a breakthrough in pharmacological tools against obesity.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
